JP2016508026A - 前立腺癌を有する個体の予後診断方法 - Google Patents

前立腺癌を有する個体の予後診断方法 Download PDF

Info

Publication number
JP2016508026A
JP2016508026A JP2015542310A JP2015542310A JP2016508026A JP 2016508026 A JP2016508026 A JP 2016508026A JP 2015542310 A JP2015542310 A JP 2015542310A JP 2015542310 A JP2015542310 A JP 2015542310A JP 2016508026 A JP2016508026 A JP 2016508026A
Authority
JP
Japan
Prior art keywords
category
biomarker
pca
composite value
snppc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015542310A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508026A5 (enExample
Inventor
ヘンリク・グレンバリ
マルティン・エクルンド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phadia AB
Original Assignee
Phadia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phadia AB filed Critical Phadia AB
Publication of JP2016508026A publication Critical patent/JP2016508026A/ja
Publication of JP2016508026A5 publication Critical patent/JP2016508026A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Computation (AREA)
  • Bioethics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Databases & Information Systems (AREA)
  • Artificial Intelligence (AREA)
  • Public Health (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
JP2015542310A 2012-11-20 2013-11-20 前立腺癌を有する個体の予後診断方法 Pending JP2016508026A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1251310 2012-11-20
SE1251310-7 2012-11-20
SE1350602-7 2013-05-16
SE1350602 2013-05-16
PCT/EP2013/074270 WO2014079874A1 (en) 2012-11-20 2013-11-20 Prognostic method for individuals with prostate cancer

Publications (2)

Publication Number Publication Date
JP2016508026A true JP2016508026A (ja) 2016-03-17
JP2016508026A5 JP2016508026A5 (enExample) 2017-01-05

Family

ID=49713059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015542310A Pending JP2016508026A (ja) 2012-11-20 2013-11-20 前立腺癌を有する個体の予後診断方法

Country Status (8)

Country Link
US (2) US10428385B2 (enExample)
EP (1) EP2922970B1 (enExample)
JP (1) JP2016508026A (enExample)
AU (1) AU2013349721B2 (enExample)
CA (1) CA2891394C (enExample)
ES (1) ES2694409T3 (enExample)
RU (1) RU2669809C2 (enExample)
WO (1) WO2014079874A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017051118A (ja) * 2015-09-08 2017-03-16 国立研究開発法人農業・食品産業技術総合研究機構 特性推定モデル生成装置および方法、解析対象の特性推定装置および方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108108590A (zh) 2012-03-05 2018-06-01 阿克蒂克合伙公司 分析系统和方法
DK2922967T3 (en) 2012-11-20 2018-04-16 Phadia Ab PROCEDURE FOR VIEWING A PRESENCE OR NON-PRESENCE OF AGGRESSIVE PROSTATANCES
AU2015230017B2 (en) * 2014-03-11 2021-06-17 A3P Biomedical Ab Method for detecting a solid tumor cancer
MX392384B (es) 2014-03-28 2025-03-24 Opko Diagnostics Llc Composiciones y metodos relacionados con el diagnostico de cancer de prostata.
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
EP3253800B1 (en) 2015-03-27 2021-03-03 Opko Diagnostics, LLC Prostate antigen standards and uses thereof
HK1247824A1 (zh) * 2015-04-29 2018-10-05 欧普科诊断有限责任公司 用於主动监控前列腺癌的组合物和方法
US20190345565A1 (en) * 2017-02-01 2019-11-14 Phadia Ab Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics
WO2019144112A1 (en) * 2018-01-22 2019-07-25 Phadia Ab Method for the harmonization of assay results

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
BRPI0807236A2 (pt) 2007-02-07 2019-09-24 Decode Genetics Ehf métodos para determinar uma suscetibilidade para câncer de próstata em um indivíduo humano, para identificar um marcador para uso em avaliação de suscetibilidade para câncer de próstata e para genotipificar uma amostra de ácido nucleico obtida de um indivíduo humano sob risco de, ou diagnosticado com, câncer de prostáta, para avaliar um indivíduo humano para probabiliade da resposta a um agente terapêutico para prevenir e/ou melhorar sintomas associados com câncer de próstata, para predizer prognóstico de um indivíduo diagnosticado com câncer e para monitorar progresso de um tratamento de um indivíduo sofrendo tratamento para câncer de próstata, kit para avaliar suscetibilidade para câncer de próstata em um indivíduo humano, uso de uma sonda de oligonucleotídeo, meio legível por computador, e , aparelho para determinar um indicador genético para câncer de próstata em um indivíduo humano.
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US20120202888A1 (en) 2010-10-08 2012-08-09 The Brigham And Women's Hospital, Inc. Biomarkers of prostate cancer and predicting mortality
US20120150032A1 (en) * 2010-12-13 2012-06-14 Julius Gudmundsson Sequence Variants Associated with Prostate Specific Antigen Levels
CA2871877A1 (en) 2012-05-16 2013-11-21 Phadia Ab Method for indicating the presence or non-presence of prostate cancer
DK2922967T3 (en) 2012-11-20 2018-04-16 Phadia Ab PROCEDURE FOR VIEWING A PRESENCE OR NON-PRESENCE OF AGGRESSIVE PROSTATANCES

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
BIOMED RESEARCH INTERNATIONAL, vol. 2014, JPN6017039912, 2014, pages 526341, ISSN: 0003664541 *
BMC MEDICINE, vol. 6, JPN6017039908, 2008, pages 19, ISSN: 0003664538 *
CANCER EPIDEMIOL. BIOMARKERS PREV., vol. 21, no. 1, JPN6017039889, January 2012 (2012-01-01), pages 212 - 216, ISSN: 0003664532 *
CANCER EPIDEMIOL. BIOMARKERS PREV., vol. 21, no. 8, JPN6017039900, August 2012 (2012-08-01), pages 1348 - 1353, ISSN: 0003664535 *
CLIN. CANCER RES., vol. 15, no. 21, JPN6017039878, 2009, pages 6658 - 6664, ISSN: 0003664529 *
EUROPEAN UROLOGY, vol. 60, JPN6017039872, 2011, pages 21 - 28, ISSN: 0003664527 *
HUMAN MOLECULAR GENETICS, vol. 20, no. 19, JPN6017039893, 2011, pages 3867 - 3875, ISSN: 0003664533 *
HUMAN MOLECULAR GENETICS, vol. 22, no. 2, JPN6017039896, October 2012 (2012-10-01), pages 408 - 415, ISSN: 0003664534 *
NAT. GENET., vol. 41, no. 10, JPN6017039881, 2009, pages 1122 - 1126, ISSN: 0003664530 *
NAT. GENET., vol. 43, no. 6, JPN6017039906, 2011, pages 570 - 573, ISSN: 0003664537 *
NAT. GENET., vol. 43, no. 8, JPN6017039875, 2011, pages 785 - 791, ISSN: 0003664528 *
NAT. GENET., vol. 45, no. 4, JPN6017039903, March 2013 (2013-03-01), pages 385 - 391, ISSN: 0003664540 *
PLOS ONE, vol. 6, no. 2, JPN6017039905, 2011, pages 17142, ISSN: 0003664536 *
PROSTATE CANCER AND PROSTATIC DISEASES, vol. 11, JPN6017039910, 2008, pages 216 - 229, ISSN: 0003664539 *
SCI. TRANSL. MED., vol. 2, no. 62, JPN6017039886, 2010, pages 62 - 92, ISSN: 0003664531 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017051118A (ja) * 2015-09-08 2017-03-16 国立研究開発法人農業・食品産業技術総合研究機構 特性推定モデル生成装置および方法、解析対象の特性推定装置および方法

Also Published As

Publication number Publication date
RU2669809C2 (ru) 2018-10-16
US20150284804A1 (en) 2015-10-08
WO2014079874A1 (en) 2014-05-30
RU2015124008A (ru) 2017-01-10
CA2891394C (en) 2023-03-14
EP2922970A1 (en) 2015-09-30
US10428385B2 (en) 2019-10-01
AU2013349721A1 (en) 2015-05-28
AU2013349721B2 (en) 2019-03-28
ES2694409T3 (es) 2018-12-20
EP2922970B1 (en) 2018-08-08
US20200010912A1 (en) 2020-01-09
CA2891394A1 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
DK2922967T3 (en) PROCEDURE FOR VIEWING A PRESENCE OR NON-PRESENCE OF AGGRESSIVE PROSTATANCES
US20200010912A1 (en) Prognostic method for individuals with prostate cancer
RU2720148C9 (ru) Способ обнаружения солидной злокачественной опухоли
US20150094221A1 (en) Method for Indicating the Presence or Non-Presence of Prostate Cancer
JP2022179483A (ja) 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法
CN105051206B (zh) 用于指示侵袭性前列腺癌的存在或不存在的方法
HK1215594B (en) Method for indicating a presence or non-presence of aggressive prostate cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161116

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180123

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180605